From: S100A14 protein as diagnostic and prognostic marker in hepatocellular carcinoma
Control group (no. = 20) | Cirrhosis group (no. = 35) | HCC group (no. = 35) | Chi-squared test | ||||||
---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | p value | |||
Sex | Female | 10 | 50.0% | 17 | 48.6% | 15 | 42.9% | 0.344 | 0.842 |
Male | 10 | 50.0% | 18 | 51.4% | 20 | 57.1% | |||
Age | Mean ± SD | 29.85 + 8.57 | 49.97 + 8.13 | 54.91 + 5.48 | 77.972 | < 0.001 | |||
Range | 20–60 | 25–60 | 40–60 |